Developer docs
API playgroundTry for free, no card

Search company profiles

National Eye Institute

Full company profile

uuid0007phk

Namestring
National Eye Institute
Legal namestring
National Eye Institute
Websiteurl
nei.nih.gov
Company typeenum
Private
Founded yearint
1968
Descriptiontext

The National Eye Institute (NEI) is a U.S. federal research institute established in 1968 as one of 27 institutes and centers comprising the National Institutes of Health (NIH), itself an agency of the U.S. Department of Health and Human Services. Headquartered at 31 Center Drive in Bethesda, Maryland, NEI operates within the NIH Intramural Research Program — described as the largest biomedical research institution in the world — and funds extramural vision research across U.S. academic and clinical institutions. Its mission is to eliminate vision loss and improve quality of life through vision research, targeting leading causes of blindness including age-related macular degeneration (AMD), glaucoma, diabetic retinopathy, and cataracts.

NEI's core technology portfolio rests on two pillars. First, POLARIS is an in-house AI/computer-vision algorithm developed by NIH researchers at NEI that analyzed imaging data from 1.3 million retinal pigment epithelial cells to produce the first subcellular-resolution digital twin of a differentiated human primary cell, intended as a platform for therapeutic discovery in AMD. Second, the "See What I See" (NEI VR) mobile application uses generative simulation across image and video modalities to depict how scenes appear to patients with AMD, glaucoma, cataracts, and diabetic retinopathy, and is distributed on iOS and Android in both English and Spanish. The institute's role as a federal entity also includes convening national surveillance and policy platforms such as the CDC's Vision and Eye Health Surveillance System (VEHSS) and the Healthy People 2030 Vision Workgroup.

NEI does not sell commercial products or services; all public-facing resources, including research findings, educational content, clinical trial information, and the VR app, are provided at no cost. The institute is funded exclusively through congressional appropriations as part of the NIH budget and derives no licensing, subscription, or transaction revenue. Its "customers" in a functional sense span the general public (consumer eye health education and clinical trial matching), vision researchers and clinicians (extramural grant funding, training programs, scientific publications), patients with eye conditions (disease education and trial access), and healthcare professionals and community educators (culturally appropriate educational materials through NEHEP). Leadership comprises Director Michael F. Chiang, M.D.; Deputy Director Santa Tumminia, Ph.D.; Scientific Director Kapil Bharti, Ph.D.; Clinical Director Richard Lee, M.D., Ph.D. (joined December 2023); and Acting Executive Director Melanie Reagan.

Short descriptiontext

The National Eye Institute is a federally funded NIH institute that conducts intramural and extramural vision research, supports clinical trials, and delivers public eye-health education to Americans, including the POLARIS AI digital-twin platform and the See What I See VR app.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersBethesda, United States
HQ citystring
Bethesda
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
vision research funding, clinical trials management, eye health education, biomedical research grants, public health information
Industry2 codes
1Neuro-Ophthalmology
CodeHLAKAKAHPrimaryYes
2Low Vision Rehabilitation
CodeHLAKAKAJPrimaryNo
NAICS code1 code
  • Offices of Optometrists621320
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Public Health Vision Research
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Federal Government Funding
TypeLicensing Royalties
Description

NEI operates as a federal institute within the National Institutes of Health (NIH), funded through congressional appropriations and federal research grants. The institute supports vision research, clinical trials, and public health education programs.

nei.nih.gov
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales, Supply Chain
GTM typeB2C
B2C
Offering typeServices
Services
Brand1 of 2 records shown
1NEI VR: See What I See
Description

A virtual reality mobile app that simulates vision loss from common eye diseases to help users understand what living with conditions like AMD, glaucoma, cataracts, and diabetic retinopathy is like.

nei.nih.gov
+1 more record
Core offering1 text field

NEI conducts intramural vision research at its Bethesda, Maryland laboratories and funds extramural vision research at institutions across the United States. The institute provides free public eye health education, coordinates and supports clinical trials for eye diseases, and develops educational and research technology tools such as the See What I See VR mobile application and the POLARIS AI-powered digital twin platform. NEI's core mission is to eliminate vision loss and improve quality of life through vision research, public education, and training of the next generation of vision scientists.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • First FDA-approved gene therapy for Leber congenital amaurosis type 2
+1 more record
Product overview1 text field

The National Eye Institute operates primarily as a research and education institution rather than a product company. Its technology offerings include the See What I See VR mobile application for public education about vision loss, and the POLARIS digital twin platform for research purposes. These tools support NEI's mission to eliminate vision loss through research funding, clinical trials coordination, and public health education programs.

Product and service4 records
1NEI VR: See What I See
CategoryMobile application
2NEI Clinical Trials Program
CategoryClinical trials program
3NEI Extramural Research Grants
CategoryResearch funding program
4National Eye Health Education Program (NEHEP)
CategoryPublic health education program
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierMinorTypeOthers
Description

Community program providing free eye care and glasses to children and adults with limited incomes who lack insurance. Part of NEI's public health outreach to connect underserved populations with vision care services.

Strategic tierMinorTypeOthers
Description

Through local Lions Clubs, provides financial assistance for eye care to community members. Some clubs also provide glasses as part of their vision-related charitable activities.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

NEI partners with CDC on the National Vision and Eye Health Surveillance System (VEHSS) to collect, analyze, and share data on eye health, eye diseases, and vision loss. CDC's Vision and Eye Health Data Portal provides detailed datasets supporting public health surveillance.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

NEI collaborates with the Census Bureau through the American Community Survey which collects data on vision difficulties. Census data on disabilities including vision impairment informs NEI's public health planning and research priorities.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

NEI leads the Healthy People 2030 Vision Workgroup, setting and tracking data-driven objectives for eye health and vision loss prevention nationally.

6Mission Cataract USA
Strategic tierMinorTypeOthers
Description

Program offering free cataract surgery to people of all ages who cannot afford the procedure. Connects patients with participating eye surgeons across the country.

nei.nih.gov
Strategic tierMinorTypeOthers
Description

Nonprofit organization with comprehensive listing of organizations and services providing financial assistance for eye care. Referenced as resource partner for low-cost eye care information.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Wilmer is one of the leading academic vision-research and clinical-care institutes in the U.S., combining intramural research, clinical trials, and physician training — closely mirroring NEI's research-plus-public-mission model.

TypeDirect peer
Description

A Harvard-affiliated specialty hospital dedicated to ophthalmology and otolaryngology, with substantial NIH-funded research labs and clinical trial programs — directly comparable in scope to NEI's intramural research and clinical mission.

TypeDirect peer
Description

Consistently top-ranked U.S. eye hospital with major NIH-funded vision research, clinical trials, and a large training portfolio — a direct academic peer to NEI's research and education activities.

TypeDirect peer
Description

UCLA's vision research and clinical-care institute, conducting NIH-funded laboratory research and training ophthalmologists — comparable in combining basic science, clinical care, and training like NEI.

TypeDirect peer
Description

One of the oldest and largest U.S. eye hospitals, with an active research institute and residency training program; a direct clinical-research peer to NEI's mission of advancing vision care.

TypeDirect peer
Description

Major U.S. non-profit that funds inherited retinal disease research, including gene and cell therapies — directly comparable to NEI's extramural grant-making role in vision research.

TypeDirect peer
Description

Non-profit funder of eye research at U.S. medical schools, providing unrestricted grants and equipment — a peer in the vision-research funding ecosystem alongside NEI's extramural grants program.

TypeDirect peer
Description

Non-profit that funds research and public education on macular degeneration, glaucoma, and Alzheimer's — overlaps with NEI's research-funding and public-education mission for the same disease areas.

TypeRegional player
Description

UK charity funding research into eye disease and vision loss — mirrors NEI's vision-research-funding and public-engagement role but operates in a different geography.

TypeBroad incumbent
Description

Sister NIH institute with a similar federal-research structure (congressional funding, intramural labs, extramural grants, clinical trials). Not a vision peer, but the closest organizational analogue within the NIH family.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment12 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

National Eye Institute

Public Health Vision Researchnei.nih.gov

The National Eye Institute is a federally funded NIH institute that conducts intramural and extramural vision research, supports clinical trials, and delivers public eye-health education to Americans, including the POLARIS AI digital-twin platform and the See What I See VR app.

What National Eye Institute does

The National Eye Institute (NEI) is a U.S. federal research institute established in 1968 as one of 27 institutes and centers comprising the National Institutes of Health (NIH), itself an agency of the U.S. Department of Health and Human Services. Headquartered at 31 Center Drive in Bethesda, Maryland, NEI operates within the NIH Intramural Research Program — described as the largest biomedical research institution in the world — and funds extramural vision research across U.S. academic and clinical institutions. Its mission is to eliminate vision loss and improve quality of life through vision research, targeting leading causes of blindness including age-related macular degeneration (AMD), glaucoma, diabetic retinopathy, and cataracts.

NEI's core technology portfolio rests on two pillars. First, POLARIS is an in-house AI/computer-vision algorithm developed by NIH researchers at NEI that analyzed imaging data from 1.3 million retinal pigment epithelial cells to produce the first subcellular-resolution digital twin of a differentiated human primary cell, intended as a platform for therapeutic discovery in AMD. Second, the "See What I See" (NEI VR) mobile application uses generative simulation across image and video modalities to depict how scenes appear to patients with AMD, glaucoma, cataracts, and diabetic retinopathy, and is distributed on iOS and Android in both English and Spanish. The institute's role as a federal entity also includes convening national surveillance and policy platforms such as the CDC's Vision and Eye Health Surveillance System (VEHSS) and the Healthy People 2030 Vision Workgroup.

NEI does not sell commercial products or services; all public-facing resources, including research findings, educational content, clinical trial information, and the VR app, are provided at no cost. The institute is funded exclusively through congressional appropriations as part of the NIH budget and derives no licensing, subscription, or transaction revenue. Its "customers" in a functional sense span the general public (consumer eye health education and clinical trial matching), vision researchers and clinicians (extramural grant funding, training programs, scientific publications), patients with eye conditions (disease education and trial access), and healthcare professionals and community educators (culturally appropriate educational materials through NEHEP). Leadership comprises Director Michael F. Chiang, M.D.; Deputy Director Santa Tumminia, Ph.D.; Scientific Director Kapil Bharti, Ph.D.; Clinical Director Richard Lee, M.D., Ph.D. (joined December 2023); and Acting Executive Director Melanie Reagan.

National Eye Institute firmographics

Firmographics
Name
National Eye Institute
Legal name
National Eye Institute
Website
https://nei.nih.gov
Company type
Private
Founded year
1968
Operating status
Operating
Headcount range
101–250 employees
Short description
The National Eye Institute is a federally funded NIH institute that conducts intramural and extramural vision research, supports clinical trials, and delivers public eye-health education to Americans, including the POLARIS AI digital-twin platform and the See What I See VR app.
Ownership category
akta.pro rank

National Eye Institute industry classification

Industry
Product category
Public Health Vision Research
NAICS
Offices of Optometrists (621320)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry
Neuro-Ophthalmology (HLAKAKAH)
akta.pro secondary industry
Low Vision Rehabilitation (HLAKAKAJ)

Keywords

  • Vision research funding
  • Clinical trials management
  • Eye health education
  • Biomedical research grants
  • Public health information

Where National Eye Institute is headquartered

Location

Headquarters

HQ city
Bethesda
HQ country
United States
HQ region
North America

Offices1 record

Markets served

National Eye Institute business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales, Supply Chain

Revenue model

  1. Federal Government Funding: NEI operates as a federal institute within the National Institutes of Health (NIH), funded through congressional appropriations and federal research grants. The institute supports vision research, clinical trials, and public health education programs.

Go-to-market motion1 record

Distribution channels4 records

Marketing channels8 records

National Eye Institute product offering

Product offering

Core offering

NEI conducts intramural vision research at its Bethesda, Maryland laboratories and funds extramural vision research at institutions across the United States. The institute provides free public eye health education, coordinates and supports clinical trials for eye diseases, and develops educational and research technology tools such as the See What I See VR mobile application and the POLARIS AI-powered digital twin platform. NEI's core mission is to eliminate vision loss and improve quality of life through vision research, public education, and training of the next generation of vision scientists.

Product overview

The National Eye Institute operates primarily as a research and education institution rather than a product company. Its technology offerings include the See What I See VR mobile application for public education about vision loss, and the POLARIS digital twin platform for research purposes. These tools support NEI's mission to eliminate vision loss through research funding, clinical trials coordination, and public health education programs.

Differentiator

Problem solved

Functional benefit

Brands

  • NEI VR: See What I See: A virtual reality mobile app that simulates vision loss from common eye diseases to help users understand what living with conditions like AMD, glaucoma, cataracts, and diabetic retinopathy is like.
  • National Eye Health Education Program (NEHEP)

Products and services

  • NEI VR: See What I See
  • NEI Clinical Trials Program
  • NEI Extramural Research Grants
  • National Eye Health Education Program (NEHEP)

Quantifiable outcome

  • First FDA-approved gene therapy for Leber congenital amaurosis type 2
  • +1 more outcomes

Companies that use National Eye Institute

Customer profile

Segments4 records

Ideal customer profiles4 records

National Eye Institute technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature3 records

National Eye Institute partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered minor and core.

  • VSP Eyes of HopeminorOthersCommunity program providing free eye care and glasses to children and adults with limited incomes who lack insurance. Part of NEI's public health outreach to connect underserved populations with vision care services.
  • Lions Clubs InternationalminorOthersThrough local Lions Clubs, provides financial assistance for eye care to community members. Some clubs also provide glasses as part of their vision-related charitable activities.
  • Centers for Disease Control and Prevention (CDC)coreStrategic or Co-development PartnerNEI partners with CDC on the National Vision and Eye Health Surveillance System (VEHSS) to collect, analyze, and share data on eye health, eye diseases, and vision loss. CDC's Vision and Eye Health Data Portal provides detailed datasets supporting public health surveillance.
  • U.S. Census BureaucoreStrategic or Co-development PartnerNEI collaborates with the Census Bureau through the American Community Survey which collects data on vision difficulties. Census data on disabilities including vision impairment informs NEI's public health planning and research priorities.
  • U.S. Department of Health and Human Services (HHS)coreStrategic or Co-development PartnerNEI leads the Healthy People 2030 Vision Workgroup, setting and tracking data-driven objectives for eye health and vision loss prevention nationally.
  • Mission Cataract USAminorOthersProgram offering free cataract surgery to people of all ages who cannot afford the procedure. Connects patients with participating eye surgeons across the country.
  • Prevent BlindnessminorOthersNonprofit organization with comprehensive listing of organizations and services providing financial assistance for eye care. Referenced as resource partner for low-cost eye care information.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

National Eye Institute competitors and assessment

Company assessment

Direct peers

  • Wilmer Eye Institute (Johns Hopkins University): Wilmer is one of the leading academic vision-research and clinical-care institutes in the U.S., combining intramural research, clinical trials, and physician training — closely mirroring NEI's research-plus-public-mission model.
  • Massachusetts Eye and Ear (Harvard): A Harvard-affiliated specialty hospital dedicated to ophthalmology and otolaryngology, with substantial NIH-funded research labs and clinical trial programs — directly comparable in scope to NEI's intramural research and clinical mission.
  • Bascom Palmer Eye Institute (University of Miami): Consistently top-ranked U.S. eye hospital with major NIH-funded vision research, clinical trials, and a large training portfolio — a direct academic peer to NEI's research and education activities.
  • Jules Stein Eye Institute (UCLA): UCLA's vision research and clinical-care institute, conducting NIH-funded laboratory research and training ophthalmologists — comparable in combining basic science, clinical care, and training like NEI.
  • Wills Eye Hospital: One of the oldest and largest U.S. eye hospitals, with an active research institute and residency training program; a direct clinical-research peer to NEI's mission of advancing vision care.
  • Foundation Fighting Blindness: Major U.S. non-profit that funds inherited retinal disease research, including gene and cell therapies — directly comparable to NEI's extramural grant-making role in vision research.
  • Research to Prevent Blindness: Non-profit funder of eye research at U.S. medical schools, providing unrestricted grants and equipment — a peer in the vision-research funding ecosystem alongside NEI's extramural grants program.
  • BrightFocus Foundation: Non-profit that funds research and public education on macular degeneration, glaucoma, and Alzheimer's — overlaps with NEI's research-funding and public-education mission for the same disease areas.

Regional players

  • National Eye Research Centre (UK): UK charity funding research into eye disease and vision loss — mirrors NEI's vision-research-funding and public-engagement role but operates in a different geography.

Broad incumbents

  • National Cancer Institute (NIH): Sister NIH institute with a similar federal-research structure (congressional funding, intramural labs, extramural grants, clinical trials). Not a vision peer, but the closest organizational analogue within the NIH family.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

National Eye Institute social profiles

Digital presence

National Eye Institute financial estimates

Financial estimate

Revenue estimate

Valuation estimate

National Eye Institute leadership team

Management profile

Number of profiles

Profiles7 records

National Eye Institute funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

National Eye Institute M&A and investment

M&A and investment

M&A

Investments12 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about National Eye Institute

What does National Eye Institute do?

NEI conducts intramural vision research at its Bethesda, Maryland laboratories and funds extramural vision research at institutions across the United States. The institute provides free public eye health education, coordinates and supports clinical trials for eye diseases, and develops educational and research technology tools such as the See What I See VR mobile application and the POLARIS AI-powered digital twin platform. NEI's core mission is to eliminate vision loss and improve quality of life through vision research, public education, and training of the next generation of vision scientists.

Is National Eye Institute a public or private company?

National Eye Institute is a private company. It is classified as state government owned and is currently operating.

When was National Eye Institute founded?

National Eye Institute was founded in 1968. It employs 101 to 250 people.

Where is National Eye Institute based?

National Eye Institute is headquartered in Bethesda, United States, in the North America region.

How does National Eye Institute make money?

One revenue line is on record: federal Government Funding.

Who are National Eye Institute's main competitors?

Direct peers on record are Wilmer Eye Institute (Johns Hopkins University), Massachusetts Eye and Ear (Harvard), Bascom Palmer Eye Institute (University of Miami), Jules Stein Eye Institute (UCLA), Wills Eye Hospital, Foundation Fighting Blindness, Research to Prevent Blindness and BrightFocus Foundation. National Eye Research Centre (UK) is listed as a regional player. National Cancer Institute (NIH) is listed as a broad incumbent.

Does National Eye Institute have an API?

No public API is recorded for National Eye Institute.

What industry is National Eye Institute in?

National Eye Institute's product category is Public Health Vision Research. Its primary akta.pro industry code is HLAKAKAH, Neuro-Ophthalmology, with a secondary code of HLAKAKAJ, Low Vision Rehabilitation. Its NAICS code is 621320 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Digital JournalClearSight Therapeutics Receives NIH SBIR Phase I Award for Conjunctivitis and EKC ResearchClearSight Therapeutics received a $306,852 NIH SBIR Phase I award from the National Eye Institute for research on a preservative-free ophthalmic formulation in acute infectious conjunctivitis and epidemic keratoconjunctivitis. The award, running from September 2026 to August 2027, provides non-dilutive capital and external validation of the company's scientific program.PR NewswirePerZeption Awarded NEI Phase 1 SBIR Grant for Age-related Macular Degeneration StudyPerZeption Inc. received a Phase I SBIR grant from the National Eye Institute for a study on photostress recovery assessment for age-related macular degeneration. The project, with UC Irvine researchers, will develop an efficient test on its AIM platform to characterize full recovery functions. The award follows validation studies and aims to support regulatory pathway for clinical use.AdvfnPerZeption Awarded NEI Phase 1 SBIR Grant for Age-related Macular Degeneration StudyPerZeption Inc. received a Phase I SBIR grant from the National Eye Institute for a study on photostress recovery assessment for age-related macular degeneration. The project, in collaboration with UC Irvine, will develop an efficient test on its AIM platform to characterize full recovery functions. The grant follows validation studies and aims to support a regulatory pathway.MorningstarPerZeption Awarded NEI Phase 1 SBIR Grant for Age-related Macular Degeneration StudyPerZeption Inc. received a Phase I SBIR grant from the National Eye Institute for a study on photostress recovery assessment for age-related macular degeneration. The study will be conducted with UC Irvine researchers to develop an efficient test on its AIM platform. The grant follows validation studies and aims to support regulatory pathway for clinical use.Mirage News$4.2M Grant Boosts Stem Cell Therapy for AMDThe National Eye Institute has awarded a nearly $4.2 million, five-year grant to Dr. Trevor McGill at Oregon Health & Science University to develop stem cell therapies for dry age-related macular degeneration. The research aims to create hypoimmune cells that can replace damaged retinal tissue without triggering immune rejection or requiring long-term immunosuppressive drugs. This funding supports preclinical studies in nonhuman primate models to evaluate the safety and effectiveness of these engineered treatments.Cornell ChronicleDiscovery could lead to drug therapy for hypopigmentation conditionsA preclinical study led by Weill Cornell Medicine and the National Eye Institute found that ampyrone, an NSAID-related compound, safely boosts melanin production in human skin. The compound increased tyrosinase activity and melanin synthesis within an hour, with no toxicity signs. Researchers are now using ampyrone as a lead compound for developing a drug for hypopigmentation disorders.BioengineeringMedical School Researcher Secures $2.2 Million NIH Grant to InvestigateA research team from the University of Minnesota Medical School has secured a $2.2 million grant from the National Eye Institute to fund a four-year investigation into retinal diseases, focusing on age-related macular degeneration and Doyne honeycomb retinal dystrophy. The project centers on understanding the molecular role of extracellular matrix protein fibulin-3 and its contribution to degenerative eye conditions, with the goal of developing novel therapeutic approaches and screening existing FDA-approved drugs for potential repurposing. The research aims to identify molecular targets within the retinal extracellular matrix that could lead to breakthrough treatments for these blinding disorders affecting millions worldwide.GlobeNewswire8 Ways to Help Protect Your Vision Right NowThe National Eye Institute released eight tips for protecting vision during Healthy Vision Month, including regular dilated exams, physical activity, and quitting smoking. The tips also cover healthy eating, wearing UV-blocking sunglasses, and managing diabetes and high blood pressure.National Center for Biotechnology InformationNIH scientists develop "digital twin" of eye cells to understand and treat age-related macular degenerationNIH researchers at the National Eye Institute have developed a 3D data-driven digital twin of retinal pigment epithelial (RPE) cells, providing the first-ever subcellular resolution digital twin of a differentiated human primary cell to study age-related macular degeneration (AMD). The team used an AI algorithm called POLARIS to analyze imaging data from 1.3 million RPE cells and created an atlas showing how healthy cells develop polarity, offering a new platform for therapeutic discovery. This technology could be adapted to study other eye and non-eye diseases affecting cell polarity.National Center for Biotechnology InformationScientists unravel genetic basis for neurodegenerative disorders that affect visionResearchers at the National Institutes of Health (NIH) and the National Eye Institute (NEI) identified that specific missense mutations in the PNPLA6 gene impair neuropathy target esterase (NTE) activity, causing neurodegenerative disorders affecting vision and mobility. The study analyzed over 100 patients and mouse models to establish a correlation between NTE activity levels and disease severity, creating a framework for categorizing these variants. This research provides a molecular basis for tailored diagnostics and potential future clinical trials targeting NTE as a biomarker.